VeriMom¿Es hydrogenated tallowamide dea seguro durante el embarazo?
No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
Related ingredients
Frequently asked questions
- ¿Es hydrogenated tallowamide dea seguro durante el embarazo?
- No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
- ¿Es hydrogenated tallowamide dea seguro durante la lactancia?
- Same evidence basis as for pregnancy: no harmonised classification or specific reproductive/developmental toxicity data were located for this CAS. Theoretical class concerns about DEA‑type substances (e.g., formation of nitrosamines or residual free DEA) are noted in broader DEA discussions but are not specific toxicological proof for this substance. Dermal exposure from cosmetics is low‑to‑measurable; breastfeeding exposure via milk is not demonstrated in the literature for this ingredient.
- ¿Es hydrogenated tallowamide dea seguro para la piel del bebé?
- No infant‑specific reproductive or developmental data were identified. Infant skin has higher surface‑area‑to‑weight and immature barrier function, so exposure score is increased by +1 relative to adult (adult e=1 → infant e=2) despite lack of data showing systemic effects. No evidence found that the ingredient is banned/restricted for infant use under EU Cosmetic Regulation.
- ¿Cómo puntúa VeriMom a hydrogenated tallowamide dea?
- VeriMom puntúa hydrogenated tallowamide dea en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hydrogenated tallowamide dea en el embarazo?
- Consulta nuestra lista de alternativas seguras a hydrogenated tallowamide dea según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.